The Coalition Government is committed to providing Australians with world class health care.
The Government has provided an additional $2.9 billion in public hospital funding over the next three years (an increase of up to 6.5% a year) through an agreement with the states and territories that places greater focus on patient outcomes, particularly when it comes to caring for patients with chronic and complex needs.
The Government is strengthening Medicare through the new Health Care Homes initiative, which will better coordinate comprehensive care for chronically ill patients.
GPs will be able to coordinate the medical, allied health and out-of-hospital services required by chronically ill patients on an ongoing basis to help manage their conditions, and in doing so keep them out of hospital.
From 1 July 2017, 65,000 Australians will initially participate in this program at up to 200 medical practices across Australia, ahead of a full national rollout.
Primary Health Networks
The Government has introduced a system of Primary Health Networks to identify local health needs, improve patient access to primary care services and improve co-ordination with local hospitals and community services.
The Government has established 31 Private Health Networks around Australia to improve access to local health services, by investing close to $1 billion.
Mental Health Reforms
The Coalition Government is delivering significant reforms that will put the individual needs of patients at the centre of our mental health system.
These reforms will reshape the delivery of primary mental health services towards a more modern, flexible model of care, rather than the current “one-size-fits-all” approach.
The Government is making medicines cheaper – in some cases by as much as 60% per script, saving patients with multiple chronic conditions as much as $500 per year.
Additional cost savings for many common medicines are due to come into effect in October 2016, as a result of changes to the way everyday drugs are priced.
The Government has put nearly 1,000 new and amended drug listings onto the Pharmaceutical Benefits Scheme, ensuring these life-saving medicines are available to all Australians, including:
Keytruda, which is used to treat Melanoma;
Mekinist, which is used to treat positive Metastatic Melanoma; and
Perjeta, Herceptin and Kadcyla, which are used to treat Breast Cancer.
The Government has also invested $1 billion to subsidise breakthrough treatments for all sufferers of Hepatitis C. These treatments would cost $100,000 per patient if not subsidised through the PBS.
Medical Research Future Fund
Australia is a world leader in the field of medical research. The $20 billion Medical Research Future Fund is providing a sustainable source of funding for vital medical research over the long term.
No Jab No Pay
To protect children from diseases, our “No Jab, No Pay” rule is removing access to family and child care payments for parents who don’t vaccinate their children.